Find the Second Entrant Sweet Spot: A DrugPatentWatch Playbook for Generic and Biosimilar Strategy
Generic & biosimilar success isnt about being first. Its about being rightat the right time.
In todays Hatch-Waxman and BPCIA game, the usual advice sounds like a mantra: be first to file.
But thats not a strategyits a slogan. In practice, the winn…
